Jm. Blasco et al., EVALUATION OF WHOLE-CELL AND SUBCELLULAR VACCINES AGAINST BRUCELLA-OVIS IN RAMS, Veterinary immunology and immunopathology, 37(3-4), 1993, pp. 257-270
Five antigen preparations from Brucella ovis strain REO 198 were incor
porated with the pluronic polymer L-121 and muramyl dipeptide and test
ed as vaccines against B. ovis infection of rams. The antigenic prepar
ations were: (1) a fraction enriched in outer membrane proteins and ro
ugh lipopolysaccharide (hot saline extract, HS); (2) the proteins from
HS substantially free of lipopolysaccharide; (3) outer membrane blebs
; (4) outer membrane-peptidoglycan complexes extracted with detergent;
(5) killed whole cells. The experimental vaccines were compared with
two standard vaccines, rough Brucella abortus 45/20 whole killed cells
in an oil based adjuvant, and live Brucella melitensis Rev 1. Immuniz
ations with non-living vaccines were performed on two occasions, 18 we
eks apart. The rams were challenged with a virulent strain of B. ovis
31 weeks after the second vaccination and slaughtered 15 weeks thereaf
ter. Rates of infection in groups vaccinated with Rev 1 (33%), and HS
(40%) were significantly lower (P<0.005 and P<0.025, respectively) tha
n that in the non-vaccinated control group (87%). Strain 45/20 was the
only other vaccine that conferred a significant level of protection (
50%) (P<0.05). The organ distribution of the infection and the level o
f colonization of infected organs did not differ significantly between
infected animals in the various vaccine groups and those in the unvac
cinated control group. No statistically significant relationship was d
etected between the magnitude of the antibody responses to the HS extr
act, to outer membrane proteins, or to the rough lipopolysaccharide, a
nd freedom from infection. The results indicate that the HS extract of
B. ovis may represent a useful alternative to B. melitensis Rev 1 or
B. abortus 45/20 as a vaccine against B. ovis.